| Bioactivity | Orexin receptor antagonist 3 (example 216) is an orexin receptor antagonist, which is extracted from the patent WO2011050198A1[1]. | ||||||||||||
| Name | Orexin receptor antagonist 3 | ||||||||||||
| CAS | 1293282-55-9 | ||||||||||||
| Formula | C21H22N8O3 | ||||||||||||
| Molar Mass | 434.45 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Wenying Chai, et al. Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators. WO2011050198A1. |
Orexin receptor antagonist 3
CAS: 1293282-55-9 F: C21H22N8O3 W: 434.45
Orexin receptor antagonist 3 (example 216) is an orexin receptor antagonist, which is extracted from the patent WO201105
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.